On Friday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) opened higher 9.45% from the last session, before settling in for the closing price of $1.27. Price fluctuations for IRWD have ranged from $0.53 to $5.13 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -47.49%. Company’s average yearly earnings per share was noted 1815.20% at the time writing. With a float of $156.35 million, this company’s outstanding shares have now reached $162.43 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Ironwood Pharmaceuticals Inc is 3.74%, while institutional ownership is 90.45%. The most recent insider transaction that took place on Aug 11 ’25, was worth 1,105. In this transaction Chief Commercial Officer of this company sold 1,316 shares at a rate of $0.84, taking the stock ownership to the 241,280 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Legal Officer sold 7,754 for $0.84, making the entire transaction worth $6,513. This insider now owns 400,378 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 0.02 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.1) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.11 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 1815.20% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Check out the current performance indicators for Ironwood Pharmaceuticals Inc (IRWD). In the past quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.73. Likewise, its price to free cash flow for the trailing twelve months is 7.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Compared to the last year’s volume of 2.64 million, its volume of 0.88 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.88%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 87.35%, which indicates a significant increase from 73.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1025 in the past 14 days, which was higher than the 0.0865 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0908, while its 200-day Moving Average is $1.5969. Nevertheless, the first resistance level for the watch stands at $1.4400 in the near term. At $1.4900, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5800. If the price goes on to break the first support level at $1.3000, it is likely to go to the next support level at $1.2100. Should the price break the second support level, the third support level stands at $1.1600.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are currently 162,434K shares outstanding in the company with a market cap of 225.78 million. Presently, the company’s annual sales total 351,410 K according to its annual income of 880 K. Last quarter, the company’s sales amounted to 85,240 K and its income totaled 23,600 K.
